drugset / Trial / NCT00618618
Phase 2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat
RandomizedParallel-groupDouble-blindTreatment
Summary
Phase 2 trial to evaluate the safety and potential efficacy of one concentration of deoxycholic acid injection, given in three dosing paradigms, compared to placebo for the reduction of submental fat (fat beneath the chin).
Timeline
- Start
- 2008-04
- Primary completion
- 2008-12
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Deoxycholic Acid | Small molecule | 0.2 ml | Other |
| Subject | Deoxycholic Acid | Small molecule | 0.4 ml | Other |
| Subject | Deoxycholic Acid | Small molecule | 10 mg/ml | Other |
Indications
No indication recorded.